Vol 7: Arsenic trioxide-based therapy in relapsed-refractory multiple myeloma patients: a meta-analysis and systematic review.Report as inadecuate



 Vol 7: Arsenic trioxide-based therapy in relapsed-refractory multiple myeloma patients: a meta-analysis and systematic review.


Vol 7: Arsenic trioxide-based therapy in relapsed-refractory multiple myeloma patients: a meta-analysis and systematic review. - Download this document for free, or read online. Document in PDF available to download.

Download or read this book online for free in PDF: Vol 7: Arsenic trioxide-based therapy in relapsed-refractory multiple myeloma patients: a meta-analysis and systematic review.
This article is from OncoTargets and therapy, volume 7.AbstractMultiple myeloma (MM) is a clonal malignancy characterized by the proliferation of malignant plasma cells in the bone marrow and the production of monoclonal immunoglobulin. Although some newly approved drugs (thalidomide, lenalidomide, and bortezomib) demonstrate significant benefit fo

Author: He, Xuepeng; Yang, Kai; Chen, Peng; Liu, Bing; Zhang, Yuan; Wang, Fang; Guo, Zhi; Liu, Xiaodong; Lou, Jinxing; Chen, Huiren

Source: https://archive.org/







Related documents